Dr Andy McEwen Executive Director, National Centre for Smoking Cessation and Training (NCSCT), London
Abstract
Smokers quitting with medication and support from trained stop smoking practitioners get not only the benefit of behavioural support, but they get more out of their stop smoking medications as well.
The NCSCT has developed an online training course for health and social care professionals that looks at how we can 'add value' to smoking cessation medications.
This presentation will preview a short film that accompanies the training course which sets out the main principles for stop smoking medications.
Source of funding: The NCSCT is supported by Public Health England. The medications training course was part-funded by an unrestricted educational grant from Pfizer.
Declaration of interest: Andy McEwen has received travel funding, honorariums and consultancy payments from manufacturers of smoking cessation products (Pfizer Ltd, Novartis UK and GSK Consumer Healthcare Ltd) and hospitality from North51 who provide online and database services. He also receives payment for providing training to smoking cessation specialists; receives royalties from books on smoking cessation and has a share in a patent of a nicotine delivery device. Andy is an Associate of the New Nicotine Alliance (NNA) that works to foster greater understanding of safer nicotine products and technologies.
